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1. Introduction
A mystery swine disease causing reproductive failure in
sows and severe pneumonia in piglets was ﬁrst described
in North America in the late 1980s and was a few years
later also observed in Europe (Keffaber, 1989; Wensvoort
et al., 1991). The etiological agent of the disease was found
to be viral and ﬁnally named Porcine Reproductive and
Respiratory Syndrome Virus (PRRSV) based on the clinical
signs (Terpstra et al., 1991; Wensvoort et al., 1991; Collins
et al., 1992). Isolation and characterization of viruses
obtained from the two continents indicated a pronounced
degree of genetic heterogeneity with only 50–60%
nucleotide identity (Wensvoort et al., 1991; Collins
et al., 1992; Allende et al., 1999). Subsequently, PRRS
viruses were divided into two major genotypes named
Type 1 for the genotype initially described in Europe and
Type 2 for the North American genotype (Allende et al.,
1999). Nowadays, both genotypes circulate worldwide (Shi
et al., 2010a).
PRRSV is an enveloped single-stranded positive-sense
RNA virus, belonging to the Arteriviridae family within
the order Nidovirales (Cavanagh, 1997). The genome is
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A B S T R A C T
Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) was ﬁrst detected
in Europe in 1996 co-incident with the introduction of a live attenuated vaccine. Since
then, only limited ORF5 and ORF7 sequences of Type 2 PRRS viruses have been reported
throughout Europe. In the present study, the genetic and antigenic diversity of 11
complete genomes and 49 ORF5 and 55 ORF7 nucleotide sequences obtained from 57
viruses in Denmark from 2003 to 2012 were examined. The genetic identity of the 11
complete genomes to the vaccine strain (Ingelvac PRRS MLV) ranged between 93.6 and
99.6% while the 49 ORF5 sequences examined were 94.0–99.8% identical to the vaccine
strain. Among the Danish sequences, the pairwise nucleotide identity was 90.9–100% and
93.0–100.0% for ORF5 and ORF7, respectively. Analysis of the genetic region encoding
NSP2 revealed high diversity among the Danish viruses with an 86.6–98.9% range in
similarity. Furthermore, several of the sequenced viruses harbored deletions in the NSP2
coding region. Phylogenetic analysis in a global Type 2 PRRSV framework classiﬁed all
Danish isolates to a single cluster (sub-lineage 5.1) which comprised strains closely-
related to the Type 2 prototype isolate VR2332.
 2013 The Authors. Published by Elsevier B.V. All rights reserved.
§ This is an open-access article distributed under the terms of the
Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduc-
tion in any medium, provided the original author and source are credited.
* Corresponding author at: National Veterinary Institute, Technical
University of Denmark, Bu¨lowsvej 27, DK-1870 Frederiksberg C, Den-
mark. Tel.: +45 35886606; fax: +45 35886340.
E-mail addresses: likik@vet.dtu.dk (L.K. Kvisgaard), ckhj@vet.dtu.dk
(C.K. Hjulsager), manreet@hku.hk (M.S. Brar), fcleung@hkucc.hku.hk
(Frederick C.C. Leung), lael@vet.dtu.dk (L.E. Larsen).
Contents lists available at ScienceDirect
Veterinary Microbiology
jou r nal h o mep ag e: w ww .e ls evier . co m/lo c ate /vetm i c
0378-1135/$ – see front matter  2013 The Authors. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.vetmic.2013.09.023
15–15.5 kb long and encodes 10 ORFs (Meulenberg et al.,
1993; Wu et al., 2001; Firth et al., 2011; Johnson et al.,
2011). ORF5, encoding the glycoprotein GP5, is one of the
most variable genes and is therefore often used in
phylogenetic analysis (Conzelmann et al., 1993; Key
et al., 2001; Shi et al., 2010b). A serological survey
performed in 1996 documented that Denmark was free
of antibodies against Type 2 PRRSV prior to the introduc-
tion of a modiﬁed live vaccine (Botner et al., 1997; Madsen
et al., 1998). Since then, Type 2 PRRSV infections have been
sporadically reported throughout Europe, however, ORF5
and ORF7 sequences of European Type 2 PRRSVs are scarce.
Apart from a Hungarian Type 2 PRRSV strain (Balka et al.,
2008), all published European Type 2 viruses shared a high
degree of identity to the PRRSV MLV vaccine strain (>98%)
which is based on the VR2332 isolate. In 2006, China
experienced the emergence of a highly pathogenic strain of
PRRSV which had a unique genomic structure (Tian et al.,
2007; An et al., 2010). The PRRSV epidemic in China
affected more than 2,000,000 pigs with about 400,000 fatal
cases. This abrupt occurrence of highly pathogenic PRRSV
strains emphasizes the signiﬁcance of monitoring the
diversity of circulating strains around the world both in
respect to the sensitivity and speciﬁcity of diagnostic tests
as well as efﬁcacy of available vaccines.
Today – more than 15 years after the initial introduc-
tion – Type 2 PRRSV still causes signiﬁcant clinical
problems in Danish herds. Previously sequenced Danish
Type 2 PRRSV isolates were reported to have a high level of
identity to the vaccine strain (Madsen et al., 1998;
Storgaard et al., 1999). However, since only a few Danish
PRRS viruses have been sequenced during the last 15 years,
the diversity of circulating Type 2 viruses in Denmark and
in the rest of Europe is unknown. This represents an
important void especially since the export of Danish pigs to
Eastern and central Europe is signiﬁcant. For example, in
2012 Denmark exported more than 9 million live pigs
whereas the import of breeding animals was much less
(n < 100). Despite this limited import of live pigs, it is still
possible that foreign PRRSV isolates may be introduced
into Denmark by contaminated transport carriers or
persons as recently seen in Sweden (Carlsson et al.,
2009). Similarly, insight into PRRSV diversity in Denmark is
of mutual interest for a range of countries. Accordingly, the
main objective of the present study was to close the
knowledge gap on the temporal diversity of circulating
Type 2 PRRS viruses in Danish pigs. A comprehensive
sequence analysis of ORF5 and its gene product, GP5, of
Danish Type 2 PRRSV viruses isolated in the years 2003–
2012 was performed and compared to the early introduced
Danish Type 2 viruses and globally isolated Type 2 viruses.
Additionally, for the ﬁrst time, a thorough genetic and
antigenic analysis of 11 complete genome sequences of
Type 2 PRRSV isolated in Europe was conducted.
2. Material and methods
2.1. Sample material
Lung tissue, serum, oral ﬂuid, and nasal swabs were
obtained from 35 Danish swine herds in the years
2003–2012. A number of strains were propagated for
one passage in Marc-145 cells using the general cell culture
procedure (Kim et al., 1993).
2.2. RNA extraction
Total RNA was extracted from serum, nasal swabs, cell
culture supernatant, and lung tissue. Lung tissue was
prepared as a 5% homogenate in RLT buffer (QIAGEN)
containing 1% b-mercaptoethanol (Sigma–Aldrich). RNA
was extracted from lung homogenate and nasal swabs
using RNeasy Minikit (QIAGEN) according to the manu-
facturer’s instructions. Total RNA from serum and cell
culture supernatant was puriﬁed using QIAamp Viral RNA
Mini Kit (QIAGEN). Elution volume for both extractions
methods was 60 ml. The RNA was stored at 80 8C until
use.
2.3. Real time RT-PCR
Puriﬁed RNA was screened for PRRSV using a modiﬁca-
tion of the Primer Probe Energy Transfer RT-PCR (PriProET-
RT-PCR) assay described by Balka et al. (2009).
2.4. cDNA synthesis and PCR ampliﬁcation
Full-genome cDNA synthesis was performed by Super-
Script1 III First-Strand Synthesis System (Invitrogen)
following the recommendations by the manufacturer
except that the cDNA synthesis step was extended to
90 min. A poly(dT) RT-primer was used as cDNA primer (50-
CAG GAA ACA GCT ATG ACA CCT GAT CTC TAG AAA CGT
T(T)38-30) (Nielsen et al., 2003). PCR ampliﬁcation of ORF5
and ORF7 was carried out using the AccuPrimeTM Taq DNA
Polymerase High Fidelity Kit (Invitrogen). The PCR mixture
was prepared as recommended by the supplier except that
the amount of AccuPrimeTM Taq High Fidelity was
increased to 0.5 ml. The PCR ampliﬁcation was conducted
on a T3 thermo cycler (Biometra) with the following
conditions: [94 8C for 15 s], 45 cycles: [94 8C 15 s, 55 8C for
30 s, 68 8C for 60 s] then ﬁnalize with 68 8C for 5 min and
cool down to 4 8C. PCR primers for amplifying ORF5 and
ORF7 were from Oleksiewicz et al. (1998). PCR products
were analyzed on 2% agarose gels (E-gels, Invitrogen).
Long range PCR ampliﬁcation was performed using the
full-genome cDNA as template with AccuPrimeTM Taq High
Fidelity kit as described by Kvisgaard et al. (2013).
2.5. Cycle sequencing and next generation sequencing
PCR products of the ORF5 and ORF7 ampliﬁcations were
sequenced by cycling sequencing using the Sanger method
(Sanger et al., 1977) with the ORF5 and ORF7 primers used
as sequencing primers (Sanger et al., 1977). In total, 39
ORF5 sequences (accession no. KC506625; KC506628-30;
KC506632-35; KC506637-41; KC506643-59; KC506661-
662; KC506665; KC506667-69; KC506671-72; KC577601)
and 45 ORF7 sequences (accession no. KC506674;
KC506677-79; KC506681-84; KC506686-90; KC506692-
712; KC506714-15; KC506718; KC506720-22; KC506724-
26; KC577602-3) were generated.
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Full genome sequences were generated by next
generation sequencing technologies (NGS) using long
range PCR amplicons covering the full genome of PRRSV
in two or four fragments as templates. For a detailed
description of the procedure and next generation sequen-
cing see Kvisgaard et al. (2013). In short, equimolar
concentration of the PCR amplicons covering the full
genome of PRRSV were prepared for sequencing on Roche/
454 Genome Sequencer FLX + Titanium (LGC Genomics
GmbH, Berlin, Germany) and Ion Torrent GPM sequencer
(DTU Multi-Assay Core (DMAC), Kgs. Lyngby, Denmark).
Additionally, full length sequences of two Danish viruses
(DK-2010-10-2-1 and DK-2010-10-7-1) were obtained
using the 454 GS Jr. platform. DNA template for these two
isolates was generated using a random PCR method
previously described (Van Doorsselaere et al., 2011).
2.6. Sequence analysis
Data analysis of ORF5 and ORF7 sequences obtained
from the cycle sequencing was carried out using the
commercial software CLC Main Workbench v. 6.6.2 (CLC
BIO, Arhus, Denmark). Contigs of ORF5 and ORF7 were
produced from assembling the raw data obtained from
cycle sequencing against the reference sequence VR2332
(PRU87392). Nucleotide and amino acid sequences were
aligned using MUSCLE (MUltiple Sequence Comparison by
Log-Expectation) (Edgar, 2004). The ORF5 sequences were
classiﬁed based on a globally representative ORF5 phylo-
genetic framework (Shi et al., 2010b). The ORF5 phyloge-
netic tree of the newly sequenced Danish isolates and
reference sequences was constructed using a Bayesian
Markov chain Monte Carlo (BMCMC) method implemen-
ted in MrBayes v3.2 (Ronquist et al., 2012) under settings
previously described (Shi et al., 2010b).
Mapping of reads obtained from full genome sequen-
cing was performed by the Burrows-Wheeler aligner
(BWA) using the bwasw algorithm for Roche 454 FLX
and Ion Torrent PGM sequencer data (Kvisgaard et al.,
2013). Amino acid sequences were predicted from the
nucleotide sequences using CLC Main Workbench v. 6.6.2.
Nucleotide and amino acid sequences were aligned using
MUSCLE (MUltiple Sequence Comparison by Log-Expecta-
tion). The phylogenetic tree constituting the complete
genomes were constructed from Neighbor Joining Algo-
rithm with Bootstrap: 1000 replicates (CLC Main Work-
bench v. 6.6.2, CLC BIO, Arhus, Denmark).
Potential N-glycosylation sites were determined for
GP2, GP3, GP4, and GP5 using NetNGlyc 1.0 Server (http://
www.cbs.dtu.dk/services/NetNGlyc/). Using a neural net-
work, N-glycosylation sites were selected when potential
above the threshold 0.5 was reached (http://
www.cbs.dtu.dk/services/NetNGlyc/output.php).
3. Results
3.1. Analysis of ORF5 and ORF7 sequences
A total of 49 ORF5 and 55 ORF7 nucleotide sequences
were obtained from 57 viruses collected in the years 2003–
2012. The lengths of the ORF5 and ORF7 sequences were
603 and 372 nucleotides, respectively. The viruses DK-
2011-30-3-13, DK-2011-30-3-15, and DK-2011-30-3-20
collected simultaneously from the same pig herd, were
almost identical and had a 3 nucleotide deletion in ORF5
(corresponding to residues114–116 in Ingelvac PRRS MLV).
This deletion was also present in two non-European
viruses, one from Thailand and one from the USA (THA-
2002-02SP3 and US-ISU3927) however these isolates
shared only 86.8% and 92.3% identity in ORF5 to these
three Danish sequences. Among the Danish sequences, the
pairwise nucleotide identity was 90.9–100% and 93.0–
100.0% for ORF5 and ORF7, respectively. The pairwise
nucleotide identity of the Danish sequences to the Ingelvac
PRRS MLV vaccine strain was in the range 94.0–99.8% and
94.6–100% in ORF5 and ORF7, respectively. Phylogenetic
analysis of ORF5 in a globally representative context (Shi
et al., 2010b) showed all the Danish viruses to be closely
related to the cluster of VR2332-like or vaccine-like strains
i.e. sub-lineage 5.1 (Fig. 1). Similar comparisons performed
exclusively among Danish isolates showed a maximum
nucleotide diversity of 9.1%. Pairwise nucleotide compar-
isons based on a partial ORF5 region (nt91-522) between
Danish Type 2 PRRS viruses and two Hungarian Type 2
PRRS viruses from 2005 to 2006 (Balka et al., 2008) showed
only 84.2–88.2% identity (data not shown).
3.2. Antigenic analysis of the amino acid sequence of the
major glycoprotein 5, GP5
Examination of the deduced amino acid sequences of
ORF5, GP5, showed that 144 positions out of 200 were
conserved in all of the 49 Danish sequences (72% conserved
sites). Twenty-four positions varied in more than one virus,
and 7 positions varied in more than 10 viruses. The most
variable position was at aa34 where 34 viruses varied. Six
different amino acid residues were seen at this site.
Interestingly, position aa34 is a putative N-glycosylation
site in Type 2 PRRS viruses. The cysteine residue at position
aa48 thought to be involved in heterodimer formation
with the M protein (Mardassi et al., 1996) was conserved in
all the Danish sequences. The decoy epitope (A/VLA/VN
motif) at position aa27–30 (Ostrowski et al., 2002) is
located in a hypervariable region of GP5 and this motif was
conserved in the majority of the Danish viruses. The
neutralizing epitope of GP5 located in the region aa37–45
(SHL/FQLIYNL) is known to be highly conserved, which also
was seen for the Danish viruses (Ostrowski et al., 2002).
Potential N-glycosylation sites were observed at seven
different positions: N30, N32, N33, N34, N35, N44, and
N51. Using a neural network, N-glycosylation sites were
predicted to be utilized if the threshold was above 0.5. The
result of these network predictions, revealed 8–9 different
putative glycosylation patterns among the Danish viruses.
N-glycosylation sites variations were located mainly
between aa30–35 near the highly variable region, includ-
ing the highly variable site at position aa34 as mention
previously. The N44 and N51 N-glycosylation sites were
conserved in all but one sequence, where N44->D44 but
the N51 glycosylation site was conserved in this virus (DK-
2012-10-1-5). The most common N-glycosylation pattern
was N30, N33, N44, and N51 which 34 viruses harbored,
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however, in 14 of these sequences N30 did not reach the
potential threshold of 0.5 and therefore was not predicted
to be N-glycosylated by the neural network.
3.3. Genetic analysis of 11 complete Danish PRRSV Type 2
genomes
Eleven complete genomes of Type 2 PRRSV (Kvisgaard
et al., 2013) isolated from Danish pig herds in the years
1997–2012 were aligned and analyzed. The genome
lengths varied from 15,396 to 15,408 nucleotides
(excluding the Poly(A) tail) and the pairwise nucleotide
identity among the Danish viruses was 90.6–99.3% and
they were 93.6–99.6% identical to the vaccine strain
Ingelvac PRRS MLV (Table 1). DK-2008-10-1-3 and DK-
2010-10-1-2 were clearly different from the majority of
Danish isolates in that the pairwise nucleotide identities
to the other Danish sequences were 92.8–95.3% and
91.1–93.6%, respectively. These two isolates were only
90.6% identical. Furthermore, DK-2010-10-1-2 shared
only 93.6% nucleotide identity to Ingelvac PRRS MLV
vaccine making it the most diverse of the Danish viruses
at the genetic level. A phylogenetic tree was constructed
with the complete Danish sequences and Type 2
sequences isolated in North America and China (Fig. 2).
Despite the fact that the Danish isolates varied up to 10%
of genomic sites, they all grouped together in a cluster
which also included the vaccine strain, VR-2332 and
three other US strains isolated in the mid-1990s. This
grouping largely mirrored the phylogenetic clustering
(lineage 5) described earlier using ORF5 only.
The pairwise nucleotide and deduced amino acid
identity of the non-structural proteins (NSP/nsp) and
structural proteins of the Danish viruses were examined.
The average similarity of the different ORFs ranged from
94.9  2.9% for ORF1a to 97.8  1.5% for ORF6. The low
average similarity of ORF1a was mainly due to the low
similarity in the coding regions of NSP1b and NSP2 which
were in the range of 85.1–99.3% and 86.6–98.9%, respectively.
The similarity of the protein products, nsp1b and nsp2, was
also low (80.8–99.5% and 94.0–98.2%), thus indicating that
most mutations in this region are non-synonymous. For a
complete overview of the pairwise identities of the different
ORFs see Supplementary Table 1.
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetmic.2013.09.023.
3.4. Examination of the non-structural protein 2 (nsp2) of the
Danish Type 2 PRRS viruses
Fig. 3 shows an alignment of the deduced nsp2 amino
acid sequences of 11 Danish viruses together with three
North American isolated Type 2 PRRS viruses reported to
be highly virulent (Han et al., 2006; Gauger et al., 2012)
and three Chinese PRRSV Type 2 viruses, one high
pathogenic (GDBY1), one low pathogenic (GDQJ), and
one (BJ-4) very similar to Ingelvac PRRS MLV (99.7%
nucleotide identity) (Yan et al., 2007; Li et al., 2010). The
virus, BJ-4, has also been used for B-cell epitope
identiﬁcations in nsp2 (Yan et al., 2007). Alignment of
Fig. 1. Phylogenetic analysis of the Danish ORF5 sequences in a globally
representative context. All the Danish sequences are marked with a red
dot, all European sequences are marked with a blue dot, and the vaccine
strain and the Type 2 protogenotype VR2332 are marked with green
triangles. All the Danish ORF5 sequences were closely related to the
cluster of VR2332-like or vaccine-like strains i.e. sub-lineage 5.1. The tree
was constructed using a BMCMC method implemented in MrBayes v3.2.
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the predicted amino acid sequence of nsp2 of the Danish
viruses with the vaccine strain revealed that several of
the Danish viruses harbored deletions resulting in
variation of the length of nsp2 from 1174 to 1096 amino
acids residues. One virus harbored a 4 amino acid
deletion following the amino acid at position 793 and
ﬁve other viruses harbored a 3 amino acid deletion at the
position corresponding to aa593–595 in nsp2 of Ingelvac
PRRS MLV. One of the viruses harboring the 3 amino acid
deletion was the virus DK-2010-10-1-2 and this virus
also had a 19 amino acid deletion corresponding to the
position aa498–516 in Ingelvac PRRS MLV nsp2. Thus,
this virus encoded the shortest nsp2 of the Danish
viruses with an amino acid length of 1174 residues. All
the deletions observed in the Danish viruses were
located at the hyper variable region between aa150–
850 of nsp2. The nsp2 protein is known to be the most
diverse protein of all the proteins encoded by PRRSV,
nevertheless, the cysteine protease domain (PL2) located
in the region aa46–146 of nsp2 is known to be conserved
within the same genotype. Indeed, this region was also
highly conserved in the Danish viruses with only 17
substitution sites out of 101positions while the North
American and Chinese viruses had only 16 and 9
substitution sites, respectively, in comparison to the
Ingelvac PRRS MLV nsp2 sequence. The amino acid
residues forming the putative catalytic triad C54, D88,
and H123 (Han et al., 2009), were conserved in all the
Danish viruses as well as in the American and Chinese
viruses. All 6 putative B-cell epitopes identiﬁed by Yan
et al. (2007) are highlighted in Fig. 3. Epitope sites SP1,
SP2, and SP4 were highly conserved among the Danish
viruses, whereas epitope sites SP5, SP6, and SP8 showed
a high proportion of variable sites (60%, 64%, and 69%,
respectively).
Comparison of the Danish nsp2 sequences to the
vaccine strain showed high similarity for 7 of the viruses
(DK-1997-19407B, DK-2004-1-7-Pl, DK-2010-10-2-1, DK-
2010-10-4-1, DK-2010-10-7-1, DK-2011-030311-1, and
DK-2012-01-11-3) with 96.2–99.3% amino acid identity
and lower similarity for 4 viruses (DK-2003-2-3, DK-2004-
2-1, DK-2008-2-1, and DK-2010-10-1-2) with amino acid
identity in the range of 89.0–92.5%.
3.5. Antigenic analysis of the minor glycoproteins, GP2, GP3,
and GP4
From the pairwise amino acid examinations, GP3 was
shown to be the most diverse structural protein among the
Danish Type 2 viruses with amino acid identity of 90.9–
99.2%. Linear B-cell epitopes have been identiﬁed in all 3
minor glycoproteins using Pepscan technologies using the
sequence of the virus strain NVSL 97-7895 (de Lima et al.,
2006). The GP2 comprised two putative linear B-cell
epitopes at amino acid positions aa41–55 and 121–135,
respectively. These regions were highly conserved among
the Danish viruses; however, the epitope located at the
region aa41–55 harbored 4 substitutions sites compared to
the NVSL 97-7895 strain. For GP3, 4 overlapping con-
secutive linear B-cell epitopes have been identiﬁed (aa61–
75, aa71–85, aa81–95, and aa91–105) (de Lima et al.,
2006). Even though GP3 was the most diverse structural
protein among the Danish Type 2 viruses, the 4 epitope
sites were all highly conserved with only 8 substitution
sites distributed throughout all 4 epitope regions (aa61–
105) when compared to the NVSL 97-7895 strain GP3
sequence (Supplementary Fig. 1). The putative epitope site
in GP4 at position aa51–65 was not conserved among the
Danish viruses with 10 substitution sites out of a possible
of 15 (Supplementary Fig. 2).
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetmic.2013.09.023.
Examination of potential N-glycosylation sites revealed
2 putative N-glycosylation sites at N178 and N184 in GP2,
7 putative N-glycosylation sites (N29, N42, N50, N131,
N152, N160, and N195) in GP3, and 4 putative N-
glycosylation sites (N37, N84, N120, and N130) in GP4.
The result of nine neural networks predicted all putative N-
glycosylation sites in GP2 and GP4 to be N-glycosylated
however N37 in GP4 did not score a unanimous vote from
the jury network to be N-glycosylated. For GP3 all 7
putative N-glycosylation sites were predicted to be N-
glycosylated in all the Danish viruses except for virus DK-
2008-10-1-3 where the potential at this position did not
reach the threshold of 0.5. A unanimous vote from the jury
predicted N-glycosylation at N195 however this position is
Table 1
Overview of the 11 Danish Type 2 PRRSV complete genomes.
Virus Accession no. Collection year Clinical signs (herd) Sequencing material Genome lengtha Nt identity%b
DK-1997-19407B KC862576 1997 Stillborn pigletc Marc-145 isolate 15,396 99.4
DK-2003-2-3 KC862584 2003 – Marc-145 isolate 15,408 96.1
DK-2004-2-1 KC862585 2004 – Marc-145 isolate 15,408 96.0
DK-2004-1-7-Pl KC862578 2004 – Marc-145 isolate 15,408 99.4
DK-2008-10-1-3 KC862582 2008 Reproductive failure Lung homogenate 15,408 95.4
DK-2010-10-1-2 KC862579 2010 Respiratory Lung homogenate 15,342 93.6
DK-2010-10-7-1 KC862580 2010 Respiratory Marc-145 isolate 15,399 98.8
DK-2010-10-2-1 KC862581 2010 Respiratory Marc-145 isolate 15,399 99.6
DK-2010-10-4-1 KC862583 2010 Respiratory Lung homogenate 15,399 98.1
DK-2011-030311-1 KC862577 2011 High fever Lung homogenate 15,408 99.3
DK-2012-01-11-3 KC862575 2012 Respiratory/
reproductive failure
Lung homogenate 15,399 98.3
a Excluding the Poly(A) tail.
b Pairwise nucleotide identity to Ingelvac PRRS MLV (EF484033).
c This virus was obtained from a non-vaccinated herd about 6 months after the Danish vaccination program had started in the fall 1996.
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believed to be located in the transmembrane region of GP3,
hence unlikely to be glycosylated (Dokland, 2010).
The cysteine residues important for protein folding and
function was 100% conserved in all the minor structural
proteins of the examined Danish viruses.
4. Discussion
We report here for the ﬁrst time the complete genome
sequences obtained from Type 2 PRRS viruses isolated in
Europe. With the 11 complete genomes sequenced from
viruses isolated in the years 1997–2012 (Kvisgaard et al.,
2013), the evolution of Type 2 PRRSV since its introduction
15 years ago in Denmark is now well described. The virus
DK-1997-19407B was isolated from a non-vaccinated herd
about 6 months after the Danish PRRSV Type 2 vaccination
program ﬁrst started in the fall of 1996 (Nielsen et al.,
2001). The complete genome of this virus was 99.4%
identical to the vaccine strain and to two other Type 2
viruses isolated in the US in 1995 and 1997, respectively.
These ﬁndings support epidemiological data indicating
that Type 2 PRRSV was likely introduced into Denmark by
the MLV vaccine.
The sudden emergence of more pathogenic PRRS
viruses in North America (Han et al., 2006; Gauger et al.,
2012), Asia (Tian et al., 2007; An et al., 2010) and Eastern
Europe (Karniychuk et al., 2010; Weesendorp et al., 2013;
Morgan et al., 2013) emphasize the importance of
monitoring the genetic diversity of PRRSV. Despite this
obvious need, there has been only a limited focus on the
genetic diversity of Type 2 PRRSV in Europe (Stadejek et al.,
2013). Thus the perception has been that all Type 2 viruses
in Europe are closely related to the attenuated vaccine
strain and are only minor contributors to clinical PRRS in
Europe. In Hungary, however, where the Ingelvac PRRS
MLV vaccine has not been used (Balka et al., 2008), two
Type 2 PRRS viruses were isolated in 2005 and 2006 that
shared higher level of identity to a Canadian strain than to
any Type 2 MLV strains, indicating that they may have
been introduced by other sources than by vaccination
(Balka et al., 2008). Pairwise nucleotide comparison of the
partial ORF5 sequences of the Hungarian viruses to the 49
Danish viruses examined in our study revealed that they
only shared 84.2–88.2% nucleotide identity and therefore
suggests that they did not originate from Denmark, despite
the use of Danish boar semen in Hungarian herds.
The majority of the 11 complete genomes showed high
level of similarity to the vaccine strain with pairwise
nucleotide identity of 98.1–99.6%. This similarity corre-
lated well with the diversity in ORF5 of the Danish viruses
where all the ORF5 sequences clustered along with the
vaccine strain in lineage 5 (Shi et al., 2010b). Interestingly,
four viruses from 2003, 2004, 2008, and 2010 showed a
higher level of diversity to the vaccine strain with 93.6–
96.1% complete genome similarity, however, they still
clustered within the lineage 5 in the phylogenetic analysis.
Based on the ORF5 nucleotide sequences obtained from all
Danish viruses isolated between 2003 and 2012, the
diversity of the Danish viruses to the vaccine strain was in
the range of 94.0–99.8%, which is a greater range than the
diversity of most European Type 2 viruses (>98% similarity
to the vaccine strain) (Greiser-Wilke et al., 2010; Stadejek
et al., 2013). The diversity among 1400 global Type 2 ORF5
sequences retrieved from a database was 3.5% (Shi et al.,
2010b) which also is less than the diversity of 9.1% seen
among the Danish ORF5 sequences. The reason for this
difference is not clear, but it indicate that the selection
pressure on Danish PRRSV strains is different than on other
Type 2 isolates maybe because it originated from an
attenuated ﬁeld strain. Most of the Danish samples
included in the present study originated from herds with
suspected acute outbreak of PRRSV. It is therefore very
unlikely that these herds vaccinated against PRRSV at the
time of submission, however, there are no reliable makers
that can be used to discriminate between the vaccine
strains and circulating Type 2 ﬁeld strains.
Notwithstanding insights based on ORF5, the examina-
tion of limited genomic regions may not be sufﬁcient for a
more complete understanding of PRRSV sequence hetero-
geneity, as illustrated by the non-structural protein coding
regions NSP1b and NSP2 of the Danish viruses that showed
a very broad range of identity to the vaccine strain of 85.1–
99.3% and 86.6–98.9%, respectively.
DK-2010-10-1-2 was the virus with the shortest
genome constituting 15,342 nucleotides resulting from a
discontinuous deletion in the coding region of NSP2 of 57
plus 9 nucleotides (corresponding to 19 plus 3 amino acids
in the deduced amino acid sequence of nsp2, Fig. 3). The
consecutive 9 nucleotide deletion was also seen in 4 other
viruses examined in this study. Although some of these
viruses were sequenced from RNA extracted from cell
Fig. 2. Phylogenetic analysis of 11 Danish complete PRRSV Type 2
genomes and 10 complete genomes of viruses isolated in China and North
America. The tree was constructed by the neighbor-joining method using
CLC Main workbench (v. 6.6.2). Bootstrap values were calculated from
1000 replicates and shown on branches. The scale bar represents 15%
nucleotide change. PRRSV Type 1 Lelystad is used as outgroup (set root
above node). CHN = China, DK = Denmark, US = United States of America.
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Fig. 3. Amino acid alignment of nsp2. Putative B-cell epitopes (Yan et al., 2007) are highlighted in black boxes. The amino acid residues forming the putative
catalytic triad C54, D88, and H123 (Han et al., 2009) are marked with black stars. Deletion sites are marked with gray rectangles.
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culture supernatant, the deletion is naturally occurring
since it was also found in partial NSP2 sequences obtained
from the corresponding primary material (data not
shown). Deletions are often seen in the NSP2 coding part
of the PRRSV genome (Ropp et al., 2004; Han et al., 2006),
and also in high virulent strains such as the MN184A and
MN184B viruses and all the high pathogenic viruses
isolated in China during the outbreak in 2006–2009 (An
et al., 2010). Based on these ﬁndings, one might presume
that deletions in NSP2 were linked to high virulence of the
virus. However, a low pathogenic virus, GDQJ (GQ374441),
isolated in 2008 was shown to harbor the exact same
deletion as the high pathogenic Chinese viruses (Li et al.,
2010). Additionally, using chimeric viruses, the NSP2
deletion in the 2006 Chinese outbreak of PRRS was shown
not to be linked to virulence (Zhou et al., 2009). In this
Fig. 3. (Continued ).
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sense, the deletions found in NSP2 of the Danish viruses
can be regarded as an ‘epidemiological marker’ and not as a
marker of virulence.
The nsp2 is the viral protein containing the highest
frequency of B-cell epitopes (Oleksiewicz et al., 2001; de
Lima et al., 2006; Yan et al., 2007) and the humoral
antibody response to nsp2 is more pronounced than
toward any other PRRSV protein. However, most of the
antibodies are non-neutralizing (Han et al., 2007; Johnson
et al., 2007; Brown et al., 2009). Analysis of the Danish
viruses showed that epitope sites SP1, SP2, and SP4
identiﬁed by Yan et al. (2007) were highly conserved
among the Danish viruses, whereas epitope sites SP5, SP6,
and SP8 showed a high proportion of variable sites of 60%,
64%, and 69%, respectively (Fig. 3). de Lima et al. (2006),
identiﬁed 18 B-cell epitopes in nsp2 of a North American
virus (NVSL 97-7895, acc. no. AY545985), but none of these
epitopes were conserved in the Danish nsp2 sequences
probably as a consequence of the high level of amino acid
variation of nsp2 (amino acid comparison of the North
American nsp2 sequence to the Danish nsp2 sequences
were 77.5–82.7% identity). The North American virus,
NVSL 97-7895 was also used for screening of linear B-cell
epitopes in the structural proteins and the epitopes
identiﬁed in GP2 and GP3 was highly conserved among
the Danish viruses and to the North American strain
although the overall amino acid variation was high in all
three minor glycoproteins compared to the Danish viruses.
The B-cell epitope identiﬁed in GP4 at position aa51–65
were highly variable with 10 substitutions out of 15
possible. This ﬁts well with previous ﬁndings that this
protein only reacted with a small fraction of tested post-
infection sera (de Lima et al., 2006). Taken together these
results indicated that some – but not all – epitopes present
in the nonstructural and structural proteins of Type 2
PRRSV are prone for changes – which again indicate that
antibodies generated against some epitopes may have no
impact on virus survival. On the other hand, the ﬁnding
that some of the epitopes were conserved despite decades
of drifts may actual indicate that conservation of these
sites favor viral survival maybe by directing immunolo-
gical attention to sites that are not harmful for the virus.
These considerations emphasize that comparisons of
complete genomes provides valuable information on
conserved and variable regions and thereby can reveal
new targets for immune intervention, the design of new
vaccines and for the development of diagnostic tests.
The N-glycosylation of GP5 may be critical for proper
functioning of the protein. N-glycosylation, in general, is
important for correct folding, targeting, and biological
activity of proteins (Ansari et al., 2006). In this study,
potential N-glycosylation sites were observed at seven
different positions in GP5. The result of a neural networks
predictions lead to 8–9 different putative glycosylation
patterns among the Danish viruses, with the N-glycosyla-
tion of N30, N33, N44, and N55 the most abundant pattern.
However, even though the N-glycosylation motif at N30
was present in 14 sequences it was not predicted to be N-
glycosylated. The position N30 is located in the C-terminal
part of the putative signal peptide and glycosylation at this
position may not have any inﬂuence on the mature protein,
but may contribute to other biological functions such as
immune evasion. The N-glycosylation at position N44 has
previously been shown to be important for infectious virus
production (Ansari et al., 2006) and only one of the
glycosylation patterns found among the Danish GP5
sequences failed to predict this site to be glycosylated.
Of the 11 complete genomes examined in this study, all
of the putative N-glycosylation motifs in the minor
glycoproteins GP2, GP3, and GP4 were present and
predicted to be N-glycosylated which strongly indicates
that the glycosylation of these motifs are important for the
functioning of the respective proteins.
In conclusion, this study presents for the ﬁrst time in-
depth analysis of complete genomes obtained from Type 2
PRRS viruses isolated in Europe. From the complete
genomes it was revealed that there was an overall high
diversity between the Danish viruses (90.6–99.3%) and one
virus was only 93.6% similar to the vaccine strain. These
results indicate that there has been pronounced genetic
drifts of the Danish Type 2 PRRSVs but the data do not
support multiple introductions of different Type 2 strains
into Denmark which ﬁts well with a limited import of
living animals and semen into Denmark. Lastly, Type 2
viruses in Denmark seem to induce more severe clinical
signs compared to other European countries but share
relatively close evolutionary relationship in ORF5 to Type 2
viruses found in other European countries. This could
indicate that the genetic determinants of viral virulence lie
outside ORF5 and emphasize that the generation of
complete genome sequences of European Type 2 isolates
should be prioritized.
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